Lexeo Therapeutics Ratios (2022-2026) | LXEO

Ratios Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Profitability
EBT Margin (Quarter) -3,211.86%
EBIT Margin (Quarter) -3,292.28%
EBITDA Margin (Quarter) -3,292.28%
Operating Margin (Quarter) -3,292.28%
Net Margin (Quarter) -3,211.86%
Efficiency
Assets Average (Quarter) 97.27M176.51M202.61M182.94M160.40M136.32M150.88M159.96M206.27M259.52M
Equity Average (Quarter) -105.97M-122.07M-137.40M-153.21M-24.64M148.24M173.95M152.14M128.08M102.48M113.17M129.52M183.75M239.08M
Invested Capital (Quarter) -98.98M-112.95M-131.18M-143.62M-162.81M113.53M182.95M164.95M139.33M116.84M88.11M138.22M120.83M246.67M231.50M
Leverage & Solvency
Interest Coverage Ratio (Quarter) -602.83-281.43-385.80-263.68-389.87-299.48-629.49-672.86-901.230.00M-0.00M-0.00M-984.00-0.00M-0.00M
Equity Ratio (Quarter) -1.16-2.980.810.860.860.800.800.700.790.840.920.92
Times Interest Earned (Quarter) -602.83-281.43-385.80-263.68-389.87-299.48-629.49-672.86-901.230.00M-0.00M-0.00M-984.00-0.00M-0.00M
Valuation
Enterprise Value (Quarter) -94.15M-77.33M-35.45M-121.47M-195.10M-175.00M-157.00M-121.52M-99.83M-132.89M-122.76M-181.77M-193.04M
Return Ratios
Return on Sales (Quarter) -0.32%
Return on Capital Employed (Quarter) -85.61%-46.82%-44.68%-59.80%-15.03%-29.56%-32.13%-19.92%-57.67%-39.86%
Return on Assets (Quarter) -0.01%0.00%0.00%0.00%-0.01%-0.01%-0.01%-0.01%0.00%0.00%
Return on Equity (Quarter) 0.00%0.00%0.03%0.00%0.00%-0.01%-0.01%-0.01%-0.01%-0.01%-0.01%0.00%